Evidence map›Paper›PMID 37974966›Full record

ArticleRSC medicinal chemistry2023

Designing photoaffinity tool compounds for the investigation of the DENV NS2B-NS3 protease allosteric binding pocket.

Hannah Maus, Andrea Gellert, Olivia R Englert, Jia-Xuan Chen, Tanja Schirmeister, Fabian Barthels

Open access · greenAbstract read
In one paragraph

Article in RSC medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hannah MausIPBS, Johannes Gutenberg-University Mainz Staudingerweg 5 55128 Mainz Germany barthels@uni-mainz.de.ORCID https://orcid.org/0000-0002-3512-5626
Andrea GellertIPBS, Johannes Gutenberg-University Mainz Staudingerweg 5 55128 Mainz Germany barthels@uni-mainz.de.
Olivia R EnglertIPBS, Johannes Gutenberg-University Mainz Staudingerweg 5 55128 Mainz Germany barthels@uni-mainz.de.
Jia-Xuan ChenIMB, Johannes Gutenberg-University Mainz Ackermannweg 4 55128 Mainz Germany.
Tanja SchirmeisterIPBS, Johannes Gutenberg-University Mainz Staudingerweg 5 55128 Mainz Germany barthels@uni-mainz.de.
Fabian BarthelsIPBS, Johannes Gutenberg-University Mainz Staudingerweg 5 55128 Mainz Germany barthels@uni-mainz.de.ORCID https://orcid.org/0000-0001-7950-2158
Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus (DENV) infection still lacks specific antiviral therapy, making the NS2B-NS3 protease an attractive target for drug development. However, allosteric inhibitors that bind to a site other than the active site still need to be better understood. In this study, we designed and synthesised tool compounds for photoaffinity labelling (PAL) to investigate the binding site of allosteric inhibitors on the DENV protease. These tool compounds contained an affinity moiety, a photoreactive group, and a reporter tag for detection. Upon irradiation, the photoreactive group formed a covalent bond with the protease, allowing for binding site identification. SDS-PAGE-based assays confirmed the qualitative binding of the designed inhibitors to the allosteric pocket, and pull-down experiments validated the interaction. Tryptic protein digestion following liquid chromatography/mass spectrometry analysis further supported the binding of the inhibitor to the proposed pocket revealing photo-attachment to an NS3 loop close to the C-terminus. These results enhance our understanding of allosteric inhibitors and their mechanism of action against the DENV protease. The developed tool compounds and PAL are potent tools for future drug discovery efforts and investigations targeting the DENV protease.

Identifiers

PMID37974966
PMCPMC10650954
OpenAlexW4387415327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.